The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: LAMIVUDINE.     Injury: Exposure during pregnancy     Quarter: 2016Q3

Total Records: 49     Number of Pages: 3

Event ID DRUGNAME PT Drug Manufacturer Patient Age Sex Weight Date (YYYYMMDD) Country
127905151 LAMIVUDINE. Exposure during pregnancy CIPLA 0.00 0 20160929 US
127905661 LAMIVUDINE. Exposure during pregnancy CIPLA 0.00 0 20160929 US
127905671 LAMIVUDINE. Exposure during pregnancy CIPLA 0.00 0 20160929 US
127983501 LAMIVUDINE. Exposure during pregnancy CIPLA 0.00 0 20160930 US
127984221 LAMIVUDINE. Exposure during pregnancy CIPLA 0.00 0 20160930 US
127985261 LAMIVUDINE. Exposure during pregnancy CIPLA 0.00 0 20160930 US
127986081 LAMIVUDINE. Exposure during pregnancy CIPLA 0.00 0 20160930 US
127987141 LAMIVUDINE. Exposure during pregnancy CIPLA 0.00 0 20160930 US
127987541 LAMIVUDINE. Exposure during pregnancy CIPLA 0.00 0 20160930 US

Total Records: 49     Number of Pages: 3